Copyright
©The Author(s) 2022.
World J Gastroenterol. Aug 7, 2022; 28(29): 3981-3993
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3981
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3981
Figure 1 Kaplan–Meier curves of global overall survival and disease-free survival.
The median overall survival (OS) and disease-free survival (DFS) were 31 mo [95% confidence interval (CI): 14-53] and 5 mo (95%CI: 1-8), respectively. 1, 3 and 5-yr OS rates were 71.4%, 43.6%, and 7.6%, respectively. 1-, and 3-yr DFS rates were 32.6%, and 16.3%, respectively. A: OS; B: DFS. OS: Overall survival; DFS: Disease-free survival.
- Citation: Risaliti M, Bartolini I, Campani C, Arena U, Xodo C, Adotti V, Rosi M, Taddei A, Muiesan P, Amedei A, Batignani G, Marra F. Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis. World J Gastroenterol 2022; 28(29): 3981-3993
- URL: https://www.wjgnet.com/1007-9327/full/v28/i29/3981.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i29.3981